Jiakang Chen, Kasim Allel, Chuyue Zhuo, Wenwei Luo, Nanhao He, Xu Yang, Yingyi Guo, Jiong Wang, Likang Yao, Jiahui Li, Yexin Lin, Ruiyang Tu, Laith Yakob, Chao Zhuo
INTRODUCTION: Although Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae (ESBL-EK) significantly contribute to bloodstream infections, their economic repercussions remain largely unquantified. DATA SOURCE AND METHODS: We performed a retrospective analysis of inpatients diagnosed with Escherichia coli or Klebsiella pneumoniae bacteremia in a tertiary hospital from January 2020 to December 2022 in Guangzhou, China. We employed the chi-square test to examine ESBL risk factors and utilized propensity score matching (PSM) to negate baseline confounding factors, assessing economic burden through disability-adjusted life years (DALYs), hospital costs and productivity losses...
2024: Risk Management and Healthcare Policy